Anonymous ID: 4a4322 April 4, 2022, 12:43 a.m. No.16008382   🗄️.is 🔗kun   >>8389

>>16008368

 

1010

04-Apr-2018 4:24:51 PM EDT

Q !xowAT4Z3VQ

8ch/qresearch

>>894110

MONEY.

POWER.

CONTROL.

People are simply in the way.

SLAVES.

SHEEP.

PAWNS.

MASS EXT EVENTS DESIGNED TO DECREASE THREAT LEVEL OF POPULATION.

GUN CONTROL.

WARS [FAKE][TOP HAPPY][BACKEND DEAL].

ELECTION RIGGING.

CONTROL.

YOUR VOICE DOES NOT MATTER.

PHARMA [CLAS-D]

WATER

AIR

CHEMICALS PUSHED FOR HOME USE CLEANING [CANCER][BABY ON FLOOR-HANDS IN MOUTH - THE START].

VACCINES [NOT ALL].

TOBACCO.

OPIOIDS.

ULTIMATE WIN [DEATH + MONEY].

THE FED.

ROTHSCHILD.

'CONSPIRACY'

'CONSPIRACY'

'CONSPIRACY'

UK/GER [5 days].

Choice is yours.

REVELATIONS.

ENOUGH IS ENOUGH.

Q

Anonymous ID: 4a4322 April 4, 2022, 12:48 a.m. No.16008389   🗄️.is 🔗kun

>>16008382

101

05-Nov-2017 7:08:10 PM EST

Anonymous

4ch/pol

 

LATEST Q VERIFIED NOV6.png

LATEST Q, along with what was posted in CBTS 68

>>148147343

Graphic confirmed.

Q

 

jD79-x10ABy-89zBT

08:00

12:00

11_6_TP_Pub

PHIL_B_O_Extract_Conf

02:00 Z

Anonymous ID: 4a4322 April 4, 2022, 1:11 a.m. No.16008430   🗄️.is 🔗kun   >>8431

>>16008420

2

"enough to improve the health of their own people.

 

Let’s be frank about this. If these epidemics were raging in the developed world, people with resources would see the suffering and insist that we stop it. But sometimes it seems that the rich world can’t even see the developing world. We rarely make eye contact with the people who are suffering—so we act sometimes as if the people don’t exist and the suffering isn’t happening.

 

All these factors together have created a tragic inequity between the health of the people in the developed world and the health of those in the rest of the world.

 

I am here today to talk about how the world, working together, can dramatically reduce this inequity.

 

I first learned about these tragic health inequities some years ago when I was reading an article about diseases in the developing world. It showed that more than half a million children die every year from “rotavirus.” I thought, “‘Rotavirus?’—I’ve never even heard of it. How could I never have heard of something that kills half a million children every year!?”

 

I read further and learned that millions of children were dying from diseases that had essentially been eliminated in the United States. Melinda and I had assumed that if there were vaccines and treatments that could save lives, governments would be doing everything they could to get them to the people who needed them. But they weren’t. We couldn’t escape the brutal conclusion that—in our world today—some lives are seen as worth saving and others are not. We said to ourselves: “This can’t be true. But if it is true, it deserves to be the priority of our giving.”

 

Today, in malaria; AIDS; tuberculosis; malnutrition; maternal, newborn, and child illness; and so many other health problems, we are not doing enough to deliver the solutions we do have, and we’re not spending enough to find the solutions we don’t have. As a result, millions of people die every year. This doesn’t tell a flattering story about humanity. But the story isn’t over. In fact, the story is starting to change."

 

I believe we are on the verge of taking historic steps to reduce disease in the developing world. What will make it possible to do something in the 21st century that we’ve never done before?

 

Science and technology.

 

Never before have we had anything close to the tools we have today to both spread awareness of the problems and discover and deliver solutions.

 

Global communications technology today can show us the suffering of human beings a world away. As the world becomes smaller, this technology will make it harder to ignore our neighbors, and harder to ignore the call of conscience to act.

 

We are seeing the power of conscience in efforts such as the United States’ Emergency Plan for AIDS, the United Kingdom’s Commission on Africa, and the Global Fund for AIDS, TB and Malaria.

 

But the desire to help means nothing without the capacity to help—and our capacity to help is increasing through the miracles of science. Again and again, over and over, scientists make the impossible possible.

 

Recent advances in basic research, particularly the sequencing of the genome, give us a foundation for much better progress against all disease. If we match these accelerating capacities of science with the emerging moral awareness of global health inequities—we have an historic chance to build a world where all people, no matter where they’re born, can have the preventive care, vaccines, and treatments they need to live a healthy life.

 

To build this world, I see four priorities:

 

First, governments in both developed and developing countries must dramatically increase their efforts to fight disease.

 

The wealthy world’s governments must not be content to merely increase their commitment every year. They need to match their commitment to the scale of the crisis. Yet, this will not happen unless we see a dramatic increase in the efforts of developing countries to fight the diseases that affect their people.

Anonymous ID: 4a4322 April 4, 2022, 1:13 a.m. No.16008431   🗄️.is 🔗kun

3

>>16008430

Countries in sub-Saharan Africa spend a smaller percentage of their gross domestic product on health than any other region of the world.

 

A stronger commitment from developing countries will inspire a stronger commitment from the rest of the world.

 

Priority number 2. The world needs to direct far more scientific research to health issues that can save the greatest number of lives – which means diseases that disproportionately affect the developing world.

 

In the early 1900s, Nobel Prizes were awarded for discoveries about the causes of both tuberculosis and malaria. Yet, more than a hundred years later, we don’t have effective vaccines for either one. It’s not because the problem is unsolvable; it’s because we haven’t put our scientific intelligence to this task. The world can change this—for malaria, tuberculosis, and so many other diseases.

 

In order to get the world’s top scientific minds to take on the world’s deadliest diseases, in 2003 our foundation launched “The Grand Challenges in Global Health.” We asked top researchers to tell us which breakthroughs could help solve the most critical health problems in the developing world. Scientists from more than 80 countries sent in thousands of pages of ideas, which led to 14 specific Grand Challenges in Global Health. Once we published these challenges, more than 10,000 scientists from over 70 countries submitted proposals for research. They included ideas such as vaccines that don’t need refrigeration, handheld microdevices that health workers can use with minimal training to detect life-threatening fevers, and drugs that can attack diseases that hide from the immune system. The quality of the ideas and the volume of the response showed us that when scientists are given a chance to study questions that could save millions of lives—they flock to it. We were so taken with the response that today we are announcing an increase of our commitment to these Grand Challenges from 200 million dollars to 450 million dollars.

 

I am optimistic. I’m convinced that we will see more groundbreaking scientific advances for health in the developing world in the next ten years than we have seen in the last fifty.

 

We’re already seeing it…

 

We’re seeing today a new, safe, cheap drug for visceral leishmaniasis, a disease that kills more than a quarter of a million people a year.

 

We’ve seen a demonstration this past year that we have a single vaccine for pneumonia that could reduce all deaths in Africa by 15 percent.

 

We are seeing older malaria drugs make way for new, more effective drugs—including new drug combinations that are extremely effective with only 3 days treatment.

 

We’ve seen a malaria vaccine in trials last year that showed promise of preventing severe malaria. This year it will move to the biggest malaria vaccine field study ever.

 

This is the first solid scientific evidence in history that a malaria vaccine for young children is possible.

 

We’ve made progress this year toward the first new drug for sleeping sickness in 50 years—an oral drug that was 100 percent effective and showed no toxicity in phase two trials.

 

One of our most daunting challenges is to create an effective vaccine to prevent HIV/AIDS. Some of the world’s top scientific minds are working on this challenge, but many of the researchers are isolated, under pressure for immediate results, and unaware of their colleagues’ discoveries.

 

Fortunately, over the past two years the global scientific community has come together under the HIV Vaccine Enterprise to coordinate AIDS vaccine research under one strategy—to help eliminate duplication, identify the gaps, and maximize the synergy from so many brilliant minds. There is a new energy around this global HIV Vaccine Enterprise, and our foundation has recently announced 400 million dollars in new funds to implement critical parts of this plan. It is time that the energy and commitment to find an HIV vaccine matched the magnitude of the pandemic.